Spectralis OCT Repeatability and Reproducibility Study
S-2013-1
Repeatability and Reproducibility of Optic Nerve Head (ONH), Retinal Nerve Fiber Layer (RNFL), and Macula Parameters With the Heidelberg Spectralis OCT.
1 other identifier
interventional
32
1 country
1
Brief Summary
This single-center, prospective, interventional clinical study is conducted to evaluate the repeatability and reproducibility of structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT (Optical Coherence Tomography) device. Data obtained from healthy volunteers in this study are compared to those from a previous, larger healthy volunteer study that was conducted in the United States and Europe (S-2012-1), and data from glaucoma patients are compared to those from the healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 12, 2013
CompletedFirst Posted
Study publicly available on registry
August 5, 2014
CompletedAugust 5, 2014
August 1, 2014
1 month
August 12, 2013
August 1, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Reproducibility and repeatability of multiple parameters (measured with OCT in the back of the eye) between different studies and different subject types
This study is designed to determine optic nerve head structural values such as ONH rim thickness, RNFL thickness values, and macula structural values such as total retinal or ganglion cell layer thickness, as measured using the Spectralis device in a population of either subjects that are determined to be clinically "normal" or "glaucomatous". The expected reproducibility and repeatability are approximately 5% or less of the respective means (coefficients of variation, cov). This study shall result in a 95% confidence interval of the cov estimate not larger than ±1% when all data is pooled (normal and glaucoma cases). Statistical analysis of the measurement values will consist of the computation of mean and standard deviation in repeated examinations with the SPECTRALIS OCT in the normal and glaucomatous population.
one day
Study Arms (2)
Healthy Volunteers
EXPERIMENTALOCT performed to collect data from the back of the eye
Glaucoma group
EXPERIMENTALOCT performed to collect data from the back of the eye
Interventions
comparative retinal parameters with Spectralis OCT
Eligibility Criteria
You may qualify if:
- Subject is not an employee of the eye clinic.
- Age ≥18
- Able and willing to undergo the test procedures, give consent, and to follow instructions.
- For "normal subjects": Healthy eye without prior intraocular surgery (except cataract surgery and Lasik - laser-assisted refractive surgery) and without clinically significant vitreal, retinal or choroidal diseases, diabetic retinopathy, or disease of the optic nerve.
- For "glaucoma subjects": Early to advanced glaucoma according to existing medical charts.
- Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.
- When both eyes are eligible, one randomly selected eye will enter the study.
You may not qualify if:
- Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:
- Retina completely included in image frame,
- Quality Score ≥ 20 in the stored ART mean images
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ophthalmology and Visual Sciences, Dalhousie University
Halifax, Nova Scotia, B3H 2Y9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Balwantray C Chauhan, PhD
Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2013
First Posted
August 5, 2014
Study Start
June 1, 2013
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
August 5, 2014
Record last verified: 2014-08